{
    "title": "Bone Marrow Stem Cells vs Diabetes",
    "inventor_name": "Julio Voltarelli",
    "publication_year": 2007,
    "device_name": "Autologous Hematopoietic Stem Cell Transplantation (AHST)",
    "goal": "Restore insulin independence in type 1 diabetes patients by resetting the immune system",
    "problem_addressed": "Autoimmune destruction of pancreatic beta cells requiring lifelong insulin therapy",
    "concept_summary": "The technique removes a patient's own bone-marrow hematopoietic stem cells, uses immunosuppressive drugs to ablate the existing immune system, then reinfuses the stem cells to re-establish immunity. The reset immune system no longer attacks insulin-producing beta cells, allowing endogenous insulin production and insulin independence.",
    "detailed_description": "In the reported clinical protocol, patients receive a short course of cytotoxic immunosuppression (e.g., cytotoxan) and antibiotics while in isolation, followed two an infusion of autologous bone-marrow stem cells via the jugular vein. Immune reconstitution is monitored through blood samples; outcomes are measured by insulin requirement and C-peptide levels. Early results show most participants become insulin-free for months to years, though some experience relapse or complications such as pneumonia or thyroid dysfunction.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Autologous stem cell transplantation",
        "Immune system ablation and reconstitution",
        "Immunomodulation of auto-reactive T cells"
    ],
    "scientific_domains": [
        "Immunology",
        "Stem Cell Biology",
        "Endocrinology"
    ],
    "mechanisms_of_action": [
        "Immune system reset",
        "Elimination of autoreactive T cells",
        "Regeneration of beta-cell function"
    ],
    "materials": [
        "Bone marrow",
        "Hematopoietic stem cells"
    ],
    "energy_sources": [],
    "inputs": [
        "Patient's bone-marrow cells",
        "Immunosuppressive drugs (e.g., cytotoxan)",
        "Antibiotics",
        "Isolation ward care"
    ],
    "outputs": [
        "Insulin independence",
        "Increased C-peptide production"
    ],
    "claimed_performance": "12 of 15 patients became insulin-free within days; average follow-up 18 months, one patient 35 months insulin-free. Later study: 6 of 9 patients insulin-free, some up to 3 years.",
    "experimental_evidence": "Clinical trial data reported in JAMA (2009), New Scientist (2007), and PLoS ONE (2012) showing insulin independence in the majority of participants after autologous hematopoietic stem-cell transplantation.",
    "replication_status": "No independent replication reported; results are limited to the original research group.",
    "keywords": [
        "type 1 diabetes",
        "stem cell transplantation",
        "autologous hematopoietic stem cells",
        "immune reset",
        "insulin independence"
    ],
    "related_technologies": [
        "Islet cell transplantation",
        "Immunosuppressive therapy"
    ],
    "controversy_level": "medium",
    "confidence_score": 0.8,
    "practicability_score": 0.6,
    "fringe_score": 0.2,
    "evidence_strength": 0.6,
    "risk_score": 0.5,
    "trl_estimate": 5,
    "source_urls": [
        "https://www.newscientist.com/article/dn11571-rebuilt-immune-system-shakes-off-diabetes/",
        "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60750-3/fulltextJulio%20Voltarelli",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285188/"
    ],
    "organizations": [
        "University of Sao Paulo",
        "University of Miami Diabetes Research Institute",
        "Ribeirão Preto School of Medicine"
    ],
    "applications": [
        "Treatment of type 1 diabetes",
        "Potential therapy for other autoimmune diseases"
    ],
    "limitations": [
        "Small sample size",
        "Lack of control group",
        "Risk of infection and other complications from immune ablation",
        "Variable patient response"
    ],
    "open_questions": [
        "How durable is insulin independence over many years?",
        "What biomarkers predict which patients will respond?",
        "Can the conditioning regimen be optimized to reduce complications?"
    ],
    "red_flags": [
        "Serious infection risk due to immune system ablation",
        "Limited independent replication of results"
    ],
    "evidence_quotes": [
        "The technique, which uses patients' own bone marrow cells, has freed 14 of 15 patients with type 1 diabetes from their dependence on insulin medication.",
        "Two weeks later, the patients received infusions of their own stem cells into their bloodstream via the jugular vein, which re-established their immune systems.",
        "Six patients obtained insulin free (IF group) and three remained insulin dependent (ID group); C-peptide production was significantly higher in IF group compared to ID group.",
        "The trial did not include a control group, and some patients may have experienced a natural remission (the 'honeymoon period') rather than a true cure.",
        "One patient developed pneumonia as a result of the immune-suppressing drugs used in the procedure."
    ]
}